Model-Informed Approach Supporting Approval of Adalimumab (HUMIRA) in Pediatric Patients with Ulcerative Colitis from a Regulatory Perspective
Ruo‐Jing Li(National University of Defense Technology), Yaning Wang(Hebei Medical University), Lesley Hanes(United States Food and Drug Administration), Hyewon Kim(Seoul National University), Jessica Lee(Boston Children's Hospital), Hao Zhu(United States Food and Drug Administration), Lian Ma(Army Medical University), Tara Altepeter(United States Food and Drug Administration), Jiang Liu(Guangdong Medical College), In‐Sook Kim(Frederick National Laboratory for Cancer Research)
Cited by 9
Related Papers
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
|Journal of Lipid Research|2007|595
Common variants at five new loci associated with early-onset inflammatory bowel disease
|Nature Genetics|2009|483
Biomarkers of aging
|Science China Life Sciences|2023|362
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
|Carcinogenesis|2006|359
DYRK1A-mediated Hyperphosphorylation of Tau
|Journal of Biological Chemistry|2007|273